Correlation Between Seres Therapeutics and Replimune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Replimune Group, you can compare the effects of market volatilities on Seres Therapeutics and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Replimune.

Diversification Opportunities for Seres Therapeutics and Replimune

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Seres and Replimune is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Replimune go up and down completely randomly.

Pair Corralation between Seres Therapeutics and Replimune

Given the investment horizon of 90 days Seres Therapeutics is expected to under-perform the Replimune. In addition to that, Seres Therapeutics is 1.44 times more volatile than Replimune Group. It trades about -0.02 of its total potential returns per unit of risk. Replimune Group is currently generating about 0.0 per unit of volatility. If you would invest  2,406  in Replimune Group on August 29, 2024 and sell it today you would lose (968.00) from holding Replimune Group or give up 40.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Seres Therapeutics  vs.  Replimune Group

 Performance 
       Timeline  
Seres Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Seres Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Seres Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Replimune Group 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Replimune Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Replimune disclosed solid returns over the last few months and may actually be approaching a breakup point.

Seres Therapeutics and Replimune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Seres Therapeutics and Replimune

The main advantage of trading using opposite Seres Therapeutics and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.
The idea behind Seres Therapeutics and Replimune Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Valuation
Check real value of public entities based on technical and fundamental data